Inform edc dcri duke10/12/2023 The DCRI was also successful in collaborating with academic partners and pharma companies outside its walls to complete successful studies and help advance development of new treatments. Projects succeeded because a unique bond formed among clinicians, statisticians, and operational experts who were able to work together seamlessly to deliver on research efforts. Harrington said the DCRI always fostered a strong collaborative spirit both internally and externally. Bloomfield professor of medicine and chairman of the department of medicine at Stanford University, said collaboration was key. Cardiologist Robert Harrington, MD, who was the DCRI’s executive director between 20 and is now Arthur L. Over the past 25 years, that vision has coalesced into five broad categories of endeavor: Generating World-Class Evidence to Improve HealthĬentral to DCRI’s vision and mission is the process of evidence generation through clinical trials and observational studies. “The Duke Clinical Research Institute, which was formally created 25 years ago, began with a vision: to usher in a different approach to learn about health and illness, and to apply these learnings to improve health care,” said Califf, who led the institute from its inception in 1996 until 2006. When current and former faculty and staff - including Hernandez and the other four individuals who have had a turn as executive director - talk about the institute, the theme that arises again and again is the DCRI’s enduring vision, which underpins its mission and activities. Food and Drug Administration).ĭuring this 25 th anniversary year, the DCRI has reflected on its first quarter-century - and on where the next quarter-century will take it. Overall, however, the thrust of the DCRI’s mission remains unchanged from what it was 25 years ago when the institute was founded by Robert Califf, MD (currently nominated for a second stint as commissioner of the U.S. Upon becoming executive director, Hernandez gently finessed the mission statement, changing “improving patient care around the world” to “improving health around the world” to reflect DCRI’s expertise in preventive care and health for all. “Everyone quickly leaned in to developing creative and trustworthy methods for addressing the most pressing questions of the pandemic.” An Enduring Vision ![]() “DCRI’s employees are profoundly mission-oriented,” said Hernandez. In response to the changing research world, Hernandez, who is also a vice dean for the Duke University School of Medicine, began to identify top priorities for the DCRI, among them a robust digital strategy and decentralized trials, which essentially take clinical trials to the subjects rather than gathering subjects together at a central site.īut as Hernandez charted the path for DCRI’s future and responded to so much change, he was also struck by what had held fast: the institute’s mission to develop, share, and implement knowledge that improves health around the world through innovative clinical research. Faced with the need to rapidly develop COVID-19 vaccines, scientific processes that would normally take years were accelerated and completed successfully in a fraction of that time. Telehealth or virtual visits became commonplace, and it soon became clear that more research could be conducted remotely outside the clinic by leveraging digital health technologies and meeting patients in their communities. Things were changing not only within the DCRI, but across the entire clinical research ecosystem. The DCRI soon became Duke University’s largest recipient of federal research dollars for COVID-19. Faculty and staff worked day and night to organize and launch new research programs aimed at answering urgent questions, such as understanding how frontline health care workers were affected by the pandemic and investigating whether approved drugs could be repurposed to treat COVID-19 symptoms at home. ![]() Experts in infectious disease, critical care, pediatrics, and cardiology alike pivoted to focus on pandemic-related research in addition to their primary research programs. Now it was all hands on deck to face COVID. The DCRI, the world’s largest academic clinical research organization, houses eight primary therapeutic areas, from musculoskeletal to neuroscience, under one roof. The world was in the early throes of the COVID-19 pandemic. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |